Free Trial

Plexus Corp. (NASDAQ:PLXS) Shares Sold by Victory Capital Management Inc.

Plexus logo with Computer and Technology background
Remove Ads

Victory Capital Management Inc. reduced its position in shares of Plexus Corp. (NASDAQ:PLXS - Free Report) by 14.6% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 170,933 shares of the technology company's stock after selling 29,253 shares during the period. Victory Capital Management Inc. owned 0.63% of Plexus worth $26,748,000 at the end of the most recent quarter.

Other institutional investors also recently bought and sold shares of the company. Quarry LP grew its position in Plexus by 573.5% in the third quarter. Quarry LP now owns 229 shares of the technology company's stock worth $31,000 after acquiring an additional 195 shares during the period. R Squared Ltd purchased a new position in shares of Plexus during the 4th quarter worth $45,000. Point72 DIFC Ltd acquired a new stake in shares of Plexus during the 3rd quarter worth about $51,000. Point72 Asia Singapore Pte. Ltd. acquired a new stake in shares of Plexus during the 3rd quarter worth about $55,000. Finally, USA Financial Formulas purchased a new stake in Plexus in the 4th quarter valued at about $56,000. 94.45% of the stock is owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other news, CEO Todd P. Kelsey sold 4,337 shares of the business's stock in a transaction dated Wednesday, February 5th. The stock was sold at an average price of $142.23, for a total value of $616,851.51. Following the completion of the sale, the chief executive officer now directly owns 80,595 shares of the company's stock, valued at approximately $11,463,026.85. The trade was a 5.11 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, insider Frank Zycinski sold 1,200 shares of the company's stock in a transaction dated Monday, February 10th. The shares were sold at an average price of $140.84, for a total value of $169,008.00. Following the completion of the sale, the insider now directly owns 723 shares of the company's stock, valued at approximately $101,827.32. This trade represents a 62.40 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 19,458 shares of company stock valued at $2,786,515. 1.76% of the stock is owned by corporate insiders.

Remove Ads

Plexus Stock Up 3.1 %

PLXS traded up $3.70 on Friday, hitting $124.21. 198,232 shares of the company were exchanged, compared to its average volume of 148,574. The company has a current ratio of 1.53, a quick ratio of 0.70 and a debt-to-equity ratio of 0.07. The company has a market cap of $3.36 billion, a price-to-earnings ratio of 28.82 and a beta of 0.90. The firm has a 50-day moving average price of $144.20 and a two-hundred day moving average price of $145.44. Plexus Corp. has a twelve month low of $90.18 and a twelve month high of $172.89.

Plexus (NASDAQ:PLXS - Get Free Report) last released its earnings results on Wednesday, January 22nd. The technology company reported $1.49 earnings per share for the quarter, missing analysts' consensus estimates of $1.59 by ($0.10). Plexus had a return on equity of 10.36% and a net margin of 3.03%. On average, equities analysts predict that Plexus Corp. will post 5.9 earnings per share for the current year.

Analysts Set New Price Targets

A number of equities research analysts have weighed in on PLXS shares. StockNews.com upgraded shares of Plexus from a "hold" rating to a "buy" rating in a research report on Monday, November 18th. Stifel Nicolaus started coverage on shares of Plexus in a report on Tuesday, February 4th. They issued a "hold" rating and a $152.00 target price for the company. Benchmark restated a "buy" rating and set a $165.00 price target on shares of Plexus in a research note on Wednesday, January 22nd. Finally, Needham & Company LLC lifted their price objective on Plexus from $162.00 to $172.00 and gave the company a "buy" rating in a research note on Friday, January 24th. Two equities research analysts have rated the stock with a hold rating and three have given a buy rating to the stock. According to MarketBeat, the company currently has an average rating of "Moderate Buy" and an average price target of $163.00.

Get Our Latest Report on Plexus

Plexus Company Profile

(Free Report)

Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.

Featured Stories

Institutional Ownership by Quarter for Plexus (NASDAQ:PLXS)

Should You Invest $1,000 in Plexus Right Now?

Before you consider Plexus, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Plexus wasn't on the list.

While Plexus currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

Institutions Are Dumping These 3 Stocks—Should You?
Will Tesla’s Robot Future Save Its Falling Stock?
NVIDIA’s Dip Is a Gift—Here’s Why It Won’t Last

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads